RBC Capital has once again stamped an "Outperform" rating on The Cigna Group, signaling steady analyst confidence. The price ...

Guggenheim has reaffirmed its buy rating on The Cigna Group, setting a target price of $388, making investors grin. The Cigna ...

UBS analyst AJ Rice reaffirmed a “Buy” rating on The Cigna Group (NYSE:CI) with a price target of $390. Rice shared his views ...

Guggenheim analyst Jason Cassorla maintained a Buy rating on Cigna (CI – Research Report) today and set a price target of $388.00. The company’s shares closed yesterday at $31 ...

Hims & Hers Health, Inc. navigates strong growth and partnerships despite rising competitive risks. Click here to read an analysis of HIMS stock now.

Wall Street’s worries about a ballooning deficit that threatens America’s status as a safe haven were reflected in a $16 billion Treasury sale that saw lackluster demand - with stocks, bonds and the ...

Detailed price information for Biomea Fusion Inc (BMEA-Q) from The Globe and Mail including charting and trades.

On Monday, Raymond (NSE: RYMD) James increased its price target on shares of CIGNA (NYSE: CI) to $385 from the previous target of $360, while reiterating a Strong Buy rating on the stock.With a market ...

Cigna’s stock price target increase at Jefferies reflects a vote of confidence in the company’s ability to maintain its strong performance and deliver value to shareholders.

Truist Financial cut their target price on shares of The Cigna Group from $390.00 to $375.00 and set a “buy” rating on the stock in a research note on Tuesday, February 4th. Cantor Fitzgerald ...

The Cigna Group (NYSE:CI – Get Free Report) ‘s stock had its “strong-buy” rating reissued by Raymond James in a report issued on Friday,Benzinga reports.They currently have a $360.00 price ...